61 related articles for article (PubMed ID: 1523341)
1. Differentiation of alveolitis and pulmonary fibrosis with a macromolecular MR imaging contrast agent.
Berthezène Y; Vexler V; Kuwatsuru R; Rosenau W; Mühler A; Clément O; Price DC; Brasch RC
Radiology; 1992 Oct; 185(1):97-103. PubMed ID: 1523341
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of capillary leak and hydrostatic pulmonary edema with a macromolecular MR imaging contrast agent.
Berthezene Y; Vexler V; Jerome H; Sievers R; Moseley ME; Brasch RC
Radiology; 1991 Dec; 181(3):773-7. PubMed ID: 1947095
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion.
Berthezène Y; Vexler V; Clément O; Mühler A; Moseley ME; Brasch RC
Radiology; 1992 Jun; 183(3):667-72. PubMed ID: 1584916
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of alveolitis and pulmonary fibrosis in rabbits with magnetic resonance imaging after intrabronchial administration of bleomycin.
Kersjes W; Hildebrandt G; Cagil H; Schunk K; von Zitzewitz H; Schild H
Invest Radiol; 1999 Jan; 34(1):13-21. PubMed ID: 9888049
[TBL] [Abstract][Full Text] [Related]
5. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine.
Vexler VS; Clément O; Brasch RC
Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273
[No Abstract] [Full Text] [Related]
6. Myocardial infarction: assessment with an intravascular MR contrast medium. Work in progress.
Saeed M; Wendland MF; Masui T; Connolly AJ; Derugin N; Brasch RC; Higgins CB
Radiology; 1991 Jul; 180(1):153-60. PubMed ID: 2052685
[TBL] [Abstract][Full Text] [Related]
7. Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine-polylysine.
Opsahl LR; Uzgiris EE; Vera DR
Acad Radiol; 1995 Sep; 2(9):762-7. PubMed ID: 9419637
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging detection of an experimental pulmonary perfusion deficit using a macromolecular contrast agent. Polylysine-gadolinium-DTPA40.
Berthezène Y; Vexler V; Price DC; Wisner-Dupon J; Moseley ME; Aicher KP; Brasch RC
Invest Radiol; 1992 May; 27(5):346-51. PubMed ID: 1582816
[TBL] [Abstract][Full Text] [Related]
9. Induction of unilateral pulmonary fibrosis in the rat by cadmium chloride.
Frankel FR; Steeger JR; Damiano VV; Sohn M; Oppenheim D; Weinbaum G
Am J Respir Cell Mol Biol; 1991 Oct; 5(4):385-94. PubMed ID: 1910823
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary oxygen toxicity: demonstration of abnormal capillary permeability using contrast-enhanced MRI.
Brasch RC; Berthezène Y; Vexler V; Rosenau W; Clément O; Mühler A; Kuwatsuru R; Shames DM
Pediatr Radiol; 1993; 23(7):495-500. PubMed ID: 8309747
[TBL] [Abstract][Full Text] [Related]
11. Early cerebral infarction: gadopentetate dimeglumine enhancement.
Elster AD; Moody DM
Radiology; 1990 Dec; 177(3):627-32. PubMed ID: 2243961
[TBL] [Abstract][Full Text] [Related]
12. Facilitated magnetic resonance imaging diagnosis of pulmonary disease using a macromolecular blood-pool contrast agent, polylysine-(Gd-DTPA)40.
Brasch RC; Berthezene Y; Vexler VS; Moseley M; Clément O; Muehler A; Price D; Jerome H
Invest Radiol; 1991 Nov; 26 Suppl 1():S42-5; discussion S60-4. PubMed ID: 1808147
[No Abstract] [Full Text] [Related]
13. [Magnetic resonance imaging of the degree of pulmonary edema using a macromolecular contrast medium].
Böck JC; Pison U; Wlodarczyk W; Kaufmann F; Lehmann J; Saupe M; Felix R
Rofo; 1997 Nov; 167(5):509-15. PubMed ID: 9440898
[TBL] [Abstract][Full Text] [Related]
14. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
Mirowitz SA; Shady KL
AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
[TBL] [Abstract][Full Text] [Related]
15. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced MR imaging of postoperative scars and VX2 carcinoma in rabbits: comparison of macromolecular contrast agent and gadopentetate dimeglumine.
Lee JW; Moon WK; Weinmann HJ; Kim SJ; Kim JH; Park SH; Kim TJ; Yoon CJ; Kim YH; Cho EY; Ha SW; Kang WS; Chang KH
Radiology; 2003 Oct; 229(1):132-9. PubMed ID: 14519873
[TBL] [Abstract][Full Text] [Related]
17. Potential of magnetic resonance lymphography with intrapulmonary injection of gadopentetate dimeglumine for visualization of the pulmonary lymphatic basin in dogs: preliminary results.
Suga K; Yuan Y; Nobuhiko O; Okada M; Kawakami Y; Matsunaga N
Invest Radiol; 2003 Nov; 38(11):679-89. PubMed ID: 14566177
[TBL] [Abstract][Full Text] [Related]
18. Gd-DTPA-polylysine-enhanced pulmonary time-of-flight MR angiography.
Böck JC; Pison U; Kaufmann F; Felix R
J Magn Reson Imaging; 1994; 4(3):473-6. PubMed ID: 8061450
[TBL] [Abstract][Full Text] [Related]
19. Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy.
Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Langer M; Claussen C; Felix R
Radiology; 1991 Feb; 178(2):503-8. PubMed ID: 1987615
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of bolus injection of gadodiamide injection and gadopentetate dimeglumine as contrast media at MR imaging in rats.
Mühler A; Saeed M; Brasch RC; Higgins CB
Radiology; 1992 May; 183(2):523-8. PubMed ID: 1561362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
